Publicaciones en las que colabora con Jaime Feliu Batlle (10)

2019

  1. SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)

    Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 46-54

2017

  1. Effectiveness and safety of aflibercept for metastatic colorectal cancer: retrospective review within an early access program in Spain

    Clinical and Translational Oncology, Vol. 19, Núm. 4, pp. 498-507

2016

  1. Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH

    Medicina Clinica, Vol. 146, Núm. 11, pp. 511.e1-511.e22

  2. Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?

    Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1072-1081

2015

  1. Clinical guideline SEOM: hepatocellular carcinoma

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 988-995

  2. Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy

    Molecular Diagnosis and Therapy, Vol. 19, Núm. 6, pp. 397-408

2014

  1. Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer

    Clinical and Translational Oncology, Vol. 16, Núm. 11, pp. 942-953

2011

  1. Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines

    Clinical and Translational Oncology, Vol. 13, Núm. 8, pp. 536-544

  2. Irinotecan-cetuximab-bevacizumab as a salvage treatment in heavily pretreated metastatic colorectal cancer patients: A retrospective observational study

    Chemotherapy, Vol. 57, Núm. 2, pp. 138-144

2009

  1. Consensus on the treatment of pancreatic cancer in Spain

    Clinical and Translational Oncology, Vol. 11, Núm. 5, pp. 290-301